Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 4/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | FAAH | O00519 | 3/20 | 0.63 |
| ▸ | BLM | P54132 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 3/20 | 0.63 |
| ▸ | HPGD | P15428 | 3/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | USP2 | O75604 | 2/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.63 |
| ▸ | RECQL | P46063 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | APEX1 | P27695 | 1/20 | 0.63 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.63 |
| ▸ | GPR18 | Q14330 | 1/20 | 0.63 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22461508 | 0.95 | HRH3 (0.66) | CNR1ALDH1A1MEN1BLMKMT2A | |
| SCHEMBL11260057 | 0.90 | HRH3 (0.71) | MEN1FAAHBLMKMT2AMAPT | |
| SCHEMBL11260061 | 0.90 | HRH3 (0.71) | MEN1FAAHBLMKMT2AMAPT | |
| Bromide SCHEMBL2169637 | 0.89 | HRH3 (0.69) | MEN1FAAHBLMKMT2AMAPT | |
| SCHEMBL28340381 | 0.88 | HRH3 (0.59) | MEN1FAAHBLMKMT2AMAPT | |
| SCHEMBL3233808 | 0.86 | MEN1 (0.62) | CNR1ALDH1A1MEN1FAAHBLM | |
| SCHEMBL3233804 | 0.86 | MEN1 (0.62) | CNR1ALDH1A1MEN1FAAHBLM | |
| SCHEMBL11731139 | 0.84 | HRH3 (0.64) | CNR1ALDH1A1MEN1BLMKMT2A | |
| SCHEMBL27447674 | 0.82 | HRH3 (0.69) | CNR1ALDH1A1MEN1BLMKMT2A | |
| SCHEMBL16626967 | 0.82 | MEN1 (0.63) | CNR1ALDH1A1MEN1BLMKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220168428-A1 | CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS | GRAPHIUM BIOSCIENCES, INC. (US) | 2022-06-02 | — | — | US | disclosed |
| US-20210052631-A1 | CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE | IONIS PHARMACEUTICALS, INC. (US) | 2021-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220168428-A1 | CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS | CNR2, CNR1, UGCG | CNR1 2/4885ALDH1A1 1324/4885MEN1 3588/4885 |
| US-20210052631-A1 | CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE | SNRPE, FABP1, RNASE1 | CNR1 4605/4885ALDH1A1 3720/4885MEN1 3943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.